Crédit Agricole Création
Investor profile
Venture capital
Crédit Agricole Création has backed 7 European tech companies across 8 funding rounds between 2018 and 2024, joining rounds totalling €227M. Most active in Healthtech and AI. Data as of Nov 2026.
Also recorded as: Credit Agricole Creation
Deals
8
distinct rounds
Companies
7
backed
Active span
2018–2024
7 yrs
Total round €
€227M
sum of rounds joined
Deals by year
distinct rounds / yearCrédit Agricole Création — deals by year — interactive chart.
Data table
| Crédit Agricole Création — deals by year | |
|---|---|
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
Top sectors
by dealsCrédit Agricole Création — top sectors — interactive chart.
Data table
| Crédit Agricole Création — top sectors | |
|---|---|
| Healthtech | 3 |
| AI | 1 |
| Cleantech | 1 |
| Energy | 1 |
| Fintech | 1 |
| Cybersecurity | 1 |
| Software | 1 |
Stages
by dealsCrédit Agricole Création — stages — interactive chart.
Data table
| Crédit Agricole Création — stages | |
|---|---|
| Other | 4 |
| Series A | 2 |
| Seed | 1 |
| Series C | 1 |
Countries
by dealsCrédit Agricole Création — countries — interactive chart.
Data table
| Crédit Agricole Création — countries | |
|---|---|
| France | 8 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Kreaxi3
- Elaia Partners2
- Fondation Fournier-Majoie2
- Sham Innovation Santé2
- Simba Santé2
- Sofinnova Partners2
- Andera Partners1
- ATEM1
- Auriga Cyber Ventures1
- Axeleo Capital1
- BNP Paribas Développement1
- Crédit Mutuel Innovation1
- CTI Life Sciences1
- EIT InnoEnergy1
- EQT Life Sciences1
- Evolem Start1
- Innobio 21
- Intermediate Capital Group1
- Kurma Partners1
- Mass General Brigham Ventures1
- Mérieux Equity Partners1
- Novo Holdings1
- Omnes Capital1
- OneRagtime1
- OrbiMed1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Amolyt Pharma | France | 1 | €129M |
| Mecaware | France | 1 | €40M |
| Mablink Bioscience | France | 2 | €35M |
| ProovStation | France | 1 | €10M |
| Tenacy | France | 1 | €6.0M |
| Tilkee | France | 1 | €3.5M |
| Aster | France | 1 | €3.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Amolyt Pharma | Series C | €129M | 2023-01 |
| Mecaware | Other | €40M | 2023-10 |
| Mablink Bioscience | Series A | €31M | 2022-10 |
| ProovStation | Series A | €10M | 2023-01 |
| Tenacy | Other | €6.0M | 2024-01 |
| Mablink Bioscience | Seed | €4.0M | 2021-04 |
| Tilkee | Other | €3.5M | 2018-02 |
| Aster | Other | €3.0M | 2021-09 |